Détail de l'auteur
Documents disponibles écrits par cet auteur
trié(s) par (Pertinence décroissant(e), Titre croissant(e)) Affiner la rechercheArticle
J. Trédaniel ; F. Barlési ; C. Le Péchoux ; D. Lerouge ; É. Pichon ; S. Le Moulec ; L. Moreau ; S. Friard ; V. Westeel ; L. Petit ; O. Carré ; F. Guichard ; O. Raffy ; J. Villa ; A. Prevost ; A. Langlais ; F. Morin ; M. Wislez ; P. Giraud ; G. Zalcman ; F. Mornex |Purpose Roughly 20% of patients with non-small-cell lung cancer exhibit locally advanced, unresectable, stage III disease. Concurrent platinum-based chemoradiotherapy is the backbone treatment, which is followed by maintenance immunotherapy, yet[...]Article
E. Rio ; F. Mornex ; P. Maingon ; D. Peiffert ; L. Parent |We present the update of the recommendations of the French society of oncological radiotherapy on hepatic tumours. Recent technological progress led to develop the concept of focused liver radiation therapy. We must distinguish primary and secon[...]Article
A. Levy ; J. Darreon ; F. Mornex ; P. Giraud ; S. Thureau |We present an update of the French society of oncological radiotherapy recommendation regarding indication, doses, and technique of radiotherapy for intrathoracic metastases. The recommendations for delineation of the target volumes and critical[...]Article
F. Huguet ; E. Rivin Del Campo ; A. Orthuon ; F. Mornex ; I. Bessieres ; V. Guimas ; V. Vendrely |We present the update of the recommendations of the French society of oncological radiotherapy on radiotherapy of pancreatic tumors. Currently, the use of radiation therapy for patients with pancreatic cancer is subject to discussion. In the adj[...]Article
E. Mesny ; F. Mornex ; A. Rode ; Philippe Merle |L’hémangiome est la tumeur bénigne la plus fréquente du foie. L’hémangiome est généralement asymptomatique mais il peut parfois provoquer des symptômes invalidants en fonction de sa taille et de sa localisation. La chirurgie et la radiologie int[...]Article
A. Escande ; P. Frey ; T. Lacornerie ; E. Mervoyer ; Cyrus Chargari ; M. Laurans ; F. Mornex ; É Marijon ; P. Giraud |Radiotherapy in patients with cardiac implantable electronic device such as pacemakers or defibrillators, is a clinical situation that is becoming increasingly common. There is a risk of interaction between the magnetic field induced by accelera[...]Article
J. Khalifa ; D. Lerouge ; C. Le Péchoux ; N. Pourel ; J. Darreon ; F. Mornex ; P. Giraud |Herein are presented the recommendations from the Société française de radiothérapie oncologique regarding indications and modalities of lung cancer radiotherapy. The recommendations for delineation of the target volumes and organs at risk are d[...]Article
B. Allignet ; Philippe Merle ; A. Rode ; J.Y. Mabrut ; K. Mohkam ; F. Mornex |Purpose: In early-stage hepatocellular carcinoma (HCC) patients merely fit for surgery, transarterial chemoembolization (TACE) achieve low long-term disease control. We evaluated the efficacy and safety of its combination with moderately hypofra[...]
